Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer.
Manola, Kalliopi N
Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer. [electronic resource] - Cancer genetics and cytogenetics Jan 2008 - 37-42 p. digital
Publication Type: Case Reports; Journal Article
0165-4608
10.1016/j.cancergencyto.2007.09.004 doi
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Chromosome Aberrations
Chromosomes, Human, Pair 12
Female
Gene Fusion
Humans
In Situ Hybridization, Fluorescence
Leukemia, Myeloid, Acute--chemically induced
Proto-Oncogene Proteins c-ets--genetics
Repressor Proteins--genetics
Translocation, Genetic
ETS Translocation Variant 6 Protein
Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer. [electronic resource] - Cancer genetics and cytogenetics Jan 2008 - 37-42 p. digital
Publication Type: Case Reports; Journal Article
0165-4608
10.1016/j.cancergencyto.2007.09.004 doi
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Chromosome Aberrations
Chromosomes, Human, Pair 12
Female
Gene Fusion
Humans
In Situ Hybridization, Fluorescence
Leukemia, Myeloid, Acute--chemically induced
Proto-Oncogene Proteins c-ets--genetics
Repressor Proteins--genetics
Translocation, Genetic
ETS Translocation Variant 6 Protein